| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9005209 | Clinical Therapeutics | 2005 | 9 Pages |
Abstract
The HMG-CoA reductase inhibitor pitavastatin was foundto be noninferior to simvastatin in terms of reducing LDL cholesterol, total cholesterol, and triglyceride levels, and increasing HDL cholesterol levels, in Korean patients with hypercholesterolemia after8 weeks of treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
MD Park, MD, PhD Kang, MD, PhD Rim, MD, PhD Ha, MD, PhD, FACC Oh, MD, PhD Chung, MD, PhD Cho,